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Background: Cytokines play an important role in the regulation of the immune response. In hepatitis C virus (HCV)
infection, cytokine levels may influence the outcome of acute HCV infection. Polymorphisms in cytokine genes have
been associated to different expression levels in response to infection. This study was carried out to investigate the
association of several cytokine gene polymorphisms with disease outcome in HCV-infected patients.
Findings: Patients with chronic or spontaneously resolved HCV infection were included in a cross-sectional study.
A comparative analysis was performed between the groups regarding frequency distribution of the following
cytokines’ gene polymorphisms: IL-10 (−1082 A/G; -819 T/C; -592 A/C), IL-4 (+33C/T), IFN-γ (+874 T/A), TNF-α
(−238 G/A and −308 G/A) and IL-28B (rs12979860 C/T and rs8099917 T/G). Results: Eighteen patients with
spontaneous viral clearance and 161 with chronic HCV infection were included. In the comparative analysis, the GG
genotype of the IL-10 polymorphism -1082A/G was more frequent in patients with spontaneous viral clearance
when compared to patients with chronic HCV (41.2% vs 6.2%; p = 0.001). This association was also found for the CC
genotype of the IL-4 polymorphism +33C/T (72.2% vs 36.7%; p = 0.017) and the CC and TT genotypes of the IL-28B
polymorphisms rs 12979860 and rs 8099917 (88.9% vs 30.3%; p < 0.001 and 88.9% vs 49.6%; p = 0.002). The IL10
(A-1082 G) and IL-28B (Crs12979860T) gene polymorphisms showed odds ratios of 12.848 and 11.077, respectively,
and thus may have a greater influence on HCV spontaneous viral clearance. The IFN-γ (+874 T/A), TNF-α (−238 G/A
and −308 G/A) polymorphisms did not show significant association with spontaneous viral clearance or chronicity.
Conclusion: The G allele for IL-10 (−1082 A/G), the C allele for IL-4 (+3 C/T) and the C and T alleles for IL-28B
(rs12979860 and rs8099917, respectively) are associated with spontaneous viral clearance in hepatitis C infection.
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Introduction
Hepatitis C virus (HCV) infection is one of the leading
causes of liver disease with approximately 180 million
people chronically infected worldwide [1]. Most HCV-
infected patients (70-80%) develop chronic hepatitis,* Correspondence: edrondin@biof.ufrj.br
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reproduction in any medium, provided the orwhich in some cases progress to liver cirrhosis (15-20%)
and hepatocellular carcinoma (1-5%). Patients with
spontaneous viral clearance are difficult to identify since
this outcome occurs mainly in the acute phase of HCV
infection, which is rarely recognized due to the lack of
symptoms and signs of liver disease.
Factors related to development of persistent infection,
which occurs in the great majority of cases, or to spontan-
eous viral clearance, are not well defined. The individual
susceptibility and the outcome of HCV infection have been
associated to polymorphisms of cytokines genes [2-5], andLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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as the immune response of the host [6,7].
The impact of the cytokine gene polymorphisms in the
pathogenesis of HCV infection has also been investigated
[8-14]. Recently, a number of studies have reported that
polymorphisms near the gene for IL-28B are strongly cor-
related with treatment response in patients with chronic
hepatitis C and also with spontaneous viral clearance
[15,16]. The aim of this study was to investigate whether
SNPs in genes involved in humoral and cellular immune
responses as well as in genes associated with activation of
the antiviral state influence the outcome of the disease
towards spontaneous viral clearance or chronicity. The
gene polymorphisms selected were chosen according to
their described role in immune and inflammatory
responses: TH1 response, IFN-γ (+874) and TNF-α
(−308 and −238); TH2 response, IL-4 (+33) and IL-10
(−1082; -819 and −592); activation of the antiviral state,
IL-28B rs 12979860 and rs 8099917.
Patient characteristics
Baseline demographic of 18 patients with acute hepatitis
C that progressed to spontaneous viral clearance, and
161 with chronic hepatitis C, are summarized in Table 1.
Patients from both groups did not differ significantly in
age (p = 0.108), gender (p = 0.145) or HCV genotype
(p = 0.149). The sample size of acute hepatitis C
patients is small due to the fact that patients in this
phase frequently go undetected, and thus are difficult
to identify. However, the statistical analysis that we
performed on the data takes into account the low
number of patients obtained.
Association of cytokine genotype and allele frequencies
with the disease outcome
Patients were genotyped for IL-10 (−592C/A, -819C/T
and -1082A/G) IL-4 (+33C/T), IFN-γ (+874 T/A), TNF-α
(−238 G/A, -308 G/A) and IL-28B (rs12979860C/T and
rs8099917T/G) gene polymorphisms. Table 2 shows theTable 1 Demographic and virological features of patients
with HCV infection
Variable Acute hepatitis C with
viral clearance
N = 18 (%)
Chronic hepatitis C
N = 161 (%)
p
Sex (number)
Female 11(61.9%) 77 (55.4%) 0.133
Male 7(38.1%) 84 (44.6%)
Age (years) 44.4 (21–73) 52.4(24–74) 0.108
Viral genotype
1 16 (88.9%) 125 (77.6%) 0.145
other 02 (11.1%) 36 (22.4%)distribution of allele and genotype frequencies for the
two groups. There were significant differences in the
genotype distribution of IL-10 (−1082A/G) (OR 3.931, CI
1.938-7.973, p = 0.001), IL-4 (+33C/T) (OR 3.879, CI
1.655-9.089, p = 0.004), and IL-28B (rs8099917T/G and
rs12979860C/T) (OR 5.021, CI 1.9-13.267 p = 0.002 and
OR 5.707, CI 2.154-15.124, p < 0.001, respectively)
polymorphisms. A higher frequency of GG genotype of
the −1082 polymorphism of the IL-10 (41.2%) and a higher
frequency of CC for +33 IL-4 polymorphism (72.2%) were
observed in patients with acute hepatitis with spontaneous
viral clearance than in patients with chronic hepatitis C
(6.2% and 36.7% respectively; p < 0.05) It is worth mentio-
ning that all patients with spontaneous viral clearance
showed GG genotype of the −1082 polymorphism of the
IL-10 together with CC genotype of the polymorphism of
IL-4 +33, forming a diplotype GGCC. For the polymorph-
isms in the gene IL-28 gene, patients with acute hepatitis
with spontaneous viral clearance had a higher frequency of
TT genotype (88.9%) of the polymorphism rs8099917 and
CC genotype (88.9%) of the polymorphism rs12979860. In
assessing the diplotype for these two polymorphisms we
found that all patients with the TT genotype of rs8099917
polymorphism also had the CC genotype polymorphism
for rs12979860. Thus, the diplotype TTCC was present in
88.9% of patients who spontaneously cleared the virus.
Finally, multifactorial analysis was performed to pre-
dict which polymorphisms most influenced spontaneous
viral clearance (Table 3). The results show that the IL-10
(−1082) (OR 12.848 p = 0.002) and IL-28B (rs12979860)
(OR 11.007 p = 0.006) gene polymorphisms have a
greater influence.
Discussion
This study aims to evaluate the genotype and allele
frequencies of IL-10 C-592A, C-819 T and A-1082 G,
IL-4 C + 33 T, IFN-γ T + 874A, and TNF-α G-238A,
G-308A, a group of cytokines representative of TH1 and
TH2 response, respectively, and IL28B Crs12979860T,
Trs8099917G a cytokine associated with the induction of
antiviral state in the cell and its association with the out-
come of HCV infection in a group of Brazilian patients.
The allele C of the IL-4 gene is more present in the
acute hepatitis C group than chronic group. To our
knowledge, this is the first reported association study of
IL-4 T + 33C polymorphism and spontaneous viral clea-
rance in hepatitis C. During the course of hepatitis C, the
IL-4 (+33) T allele is associated with higher expression of
IL-4 gene [17] and with recurrence of infection after liver
transplantation due to hepatitis C and more severe hep-
atic lesion [18]. The high production of IL-4 by the IL-4
(+33) TT genotype leads to a decrease in viral elimination
by down regulation of the TH1 response, thereby affecting
control of the viral infection. Thus, an increase in IL-4
Table 2 Genotype and allele frequencies of cytokine
genotypes in patients with acute hepatitis C with viral










IL-10 n = 17 n = 161
(−1082) A/A 07 (41.2%) 106 (65.8%)
A/G 03 (17.6%) 45 (28%)
G/G 07 (41.2%) 10 (6.2%) 0.001*
A 17 (50%) 257 (79.8%)
G 17 (50%) 65 (20.2%) 0.001*
(−819) C/C 08 (47.1%) 58 (36%)
C/T 05 (29.4%) 60 (37.3%)
T/T 04 (23.5%) 43 (26.7%) 0.504
C 21 (61.8%) 176 (54.7%)
T 13 (38.2%) 146 (45.3) 0.101
IL-4 n = 18 n = 147
(+33) C/C 13 (72.2%) 54 (36.7%)
C/T 04 (22.2%) 53 (36.1%)
T/T 01 (5.6%) 40 (27.2%) 0.017*
C 30 (73.4%) 161 (54.8%)
T 06 (16.6%) 133 (45.2%) 0.004*
IFN-γ n = 18 n = 149
(+874) T/T 02 (11.1%) 25 (16.4%)
T/A 09 (50%) 66 (44.3%)
A/A 07 (38.9%) 58 (38.9%) 0.804
T 13 (36.2%) 116 (38.9%)
A 23 (63.8%) 182 (61.1%) 0.858
TNF-α n = 18 n = 124
(−308) G/G 10 (61.9%) 75 (59.5%)
G/A 03 (14.3%) 27 (22.3%)
A/A 05 (23.8%) 22 (18.2%) 0.580
G 23 (63.9%) 177 (71.4%)
A 13 (36.1%) 71 (28.6%) 0.832
(−238) G/G 16 (88.9%) 114 (91.9%)
G/A 02 (11.1%) 10 (8.1%) 0.560
G 34 (94.5%) 238 (96%)
A 02 (5.5%) 10 (4%) 0.388
IL-28B n = 18 n = 119
(rs12979860) C/C 16 (88.9%) 36 (30.3%)
C/T 00 (0.0%) 61 (51.3%)
T/T 02 (11.1%) 22 (18.5%) <0.001*
C 32 (88.9%) 133 (55.9%)
T 04 (11.1%) 105 (44.1%) <0.001*
n = 18 n = 133
(rs8099917) T/T 16 (88.9%) 66 (49.6%)
T/G 00 (0.0%) 25 (18.8%)
Table 2 Genotype and allele frequencies of cytokine
genotypes in patients with acute hepatitis C with viral
clearance and patients with chronic hepatitis C
(Continued)
G/G 02 (11.1%) 42 (31.6%) 0.002*
T 32 (88.9%) 157 (59%)
G 04 (11.1%) 109 (41%) <0.001*
* p < 0.05.
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other hand, no association was found between the IL-4
(−589) gene polymorphism and chronic hepatitis C [20].
The mechanisms responsible for the observed associa-
tions between IL-10 polymorphisms and viral infection
are still unclear, but appear to be related to the level of
IL-10 gene expression and the corresponding effects on
the TH1 response and modulation of inflammation.
SNPs in the promoter region of the IL-10 gene have
been associated with low levels of IL-10 and with
chronic inflammatory response in many diseases [8,9].
Individuals with IL-10 (−1082) GG genotype produce
higher levels of IL-10 than GA or AA individuals [21].
Also, IL-10 is a potent inhibitor of pro-inflammatory
mediators such as IL-1, TNF-α, IL-6 [10] and IFN-γ
[11]. Theoretically, high production of IL-10 could facili-
tate viral escape by down regulating the protective TH1
response, but at the same time be beneficial to the pa-
tient due to its anti-fibrogenic properties that could lead
to a slow progression of liver disease [12]. In this study,
the AA genotype for IL-10 (−1082) was more frequently
observed in patients with chronic hepatitis C when com-
pared to those that resolved infection spontaneously.
The higher prevalence of genotype AA, associated with
low IL-10 production, may lead to a lower efficiency in
the antiviral immune response. Our results suggest that
a higher production of IL-10 may be associated with
spontaneous viral clearance. In agreement with our
results, Lio et al., 2003, [13] described an association be-
tween high IL-10 production and viral clearance. Thus,
the predominance of IL-10 (−1082) GG genotype, asso-
ciated with high IL-10 gene expression, in patients with
spontaneous viral clearance may contribute to theTable 3 Multifactorial analysis of association of IL-10, IL-4







IL-10 (−1082) 12.848 2,478 66,606 0.002
IL-28B (rs12979860) 11.077 2.013 60.960 0.006
IL-28B (rs8099917) 5.383 0.801 36.166 0.083
IL-4 (+33) 2.467 0.633 9.610 0.193
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gene polymorphisms described (−819 and −592) are in
linkage disequilibrium and no association with HCV in-
fection was observed [13,21].
Gajewski et al., 1989, demonstrated that low levels of
IFN-γ were associated with persistent HCV infection
[14]. IFN-γ gene polymorphisms influence its expression,
changing the levels of the cytokine, which may lead to
different outcomes of the viral infection as mentioned
above. In this study, no differences were found in the
distribution of genotypic and allelic frequencies between
patients with acute hepatitis C that cleared spontan-
eously and patients with chronic hepatitis C infection.
These results are in agreement with those described by
Pereira et al., 2008 [22]. However Ben-Ari et al., 2004 [23]
reported the association of low expression genotypes of
IFN-γ T + 874A polymorphism with early recurrent hepa-
titis C after liver transplantation. The association of the
IFN-γ T + 874A polymorphism and chronicity of HCV in-
fection is, however, still controversial.
The persistence of the virus and the response to anti-
viral therapy have been suggested to be associated with
the production of inappropriate levels of TNF-α [24].
Nevertheless, this study did not find any differences in
the distribution of genotypic and allelic frequencies, of
the polymorphisms −238 and −308 of TNF-α, between
patients with spontaneous viral clearance and patients
with chronic hepatitis C, which is in accordance with
other studies [13,22].
Several studies have demonstrated an association of
SNPs in the IL-28B gene with response to treatment and
spontaneous viral elimination in patients with HCV. Two
of these polymorphisms, known as rs8099917 and
rs12979860, have been strongly associated with non-
response to treatment [15,16,25-29]. Our study shows that
the genotypic frequency for the two polymorphisms in the
IL-28B gene was associated with spontaneous viral clear-
ance. Both polymorphisms, rs12979860 and rs8099917,
were associated with spontaneously viral clearance in com-
parison with the chronically infected patients. The CC and
TT genotypes (for rs12979860 and rs8099917, respectively)
correspond to a positive predictive value of 89% for spon-
taneous viral clearance. These genotypes were also asso-
ciated with spontaneous clearance of HCV in other studies
[15,25,26,30]. These associations presumably are related to
the ability of IL-28B to induce the antiviral state. In
addition, when analyzing the influence of these polymor-
phisms in spontaneous viral clearance, we found a strong
association with IL-10 (−1082) and IL-28B (rs12979860)
gene polymorphisms, while IL-4 (+33) and IL-28B
(rs8099917) gene polymorphisms had a lower influence on
spontaneous viral clearance. Since the age of infection of
chronic hepatitis C patients could not be determined, a
limitation of the study, the ages of infection in both groupscould have been different. We therefore cannot exclude
the influence of different ages of infection on the observed
associations. In summary, our study shows that IL-10 and
IL-28B gene polymorphims have a greater, and IL-4 gene
polymorphism a lower, influence on the clinical outcome
of HCV infection in a Brazilian population.
Conclusion
In conclusion: our findings show that polymorphisms in
cytokine genes related to the immune response may in-
fluence the outcome of acute HCV of infection by the
hepatitis C virus.
Patients and methods
A cross-sectional study of 161 individuals with chronic
HCV infection attending the Liver Clinic of the Clemen-
tino Fraga Filho University Hospital (HUCFF) were
selected from 2008 to 2010 and a cohort of 18 patients
with acute hepatitis C and spontaneous viral clearance
were selected from the Viral Hepatitis Clinic of the
Oswaldo Cruz Foundation (FIOCRUZ). This cohort of
patients with acute HCV infection was previously evalu-
ated by clinical and laboratory parameters [31]. Patients
with undetected HCV RNA in three consecutive tests
within 12-months of follow-up were considered as hav-
ing spontaneous viral clearance. Further details were
described elsewhere [31]. The inclusion criteria for
chronic hepatitis C patients were: detectable anti-HCV
antibodies with detectable serum, HCV RNA for
6 months of follow up, and a liver biopsy with character-
istics of chronic HCV infection. Patients with clinical
diagnosis of compensated liver cirrhosis (Child-Pugh A)
were also included. Exclusion criteria were: HBV or HIV
co-infection, alcohol ingestion, other etiologies of
chronic liver disease and patients with HCV infection
who were submitted to organ transplant. The age at
HCV infection of chronic patients could not be deter-
mined. Written informed consent was obtained from
each patient. The Research and Ethics Committee board
of the HUCFF approved the study protocol.
Genomic DNA was extracted from peripheral blood
using standard inorganic salting-out procedures [32].
IFN-γ +874 T/A, IL-4 +33C/T, TNF-α -238 G/A,
-308 G/A, IL-10 -592C/A, -819C/T and -1082A/G and
IL28B rs12979860 C/T and rs8099917T/G gene poly-
morphisms were genotyped using PCR and specific pri-
mers as follows: IFN-γ, F-50-GGAACTTCGTTGCTCA
CTGGG-30 and R-50-CTATTACATCTACTGTGCCTT
CCTG-30 in a 35 cycles at 94oC for 30 seconds, 58oC
for 45 seconds and 72oC for 1 min; IL-4, F- 50- CAATG
TAAACTCATTTTCCCTCG-30 and R-50-AGAAATACT
GAGAGCATCACCAG-30 in 35 cycles at 94°C for 30 s,
54°C for 45 s and 72oC for 1 min; IL-10, C-592A, C-
819 T and A-1082 G F- 50-CTCGTCGCAACCCAAC
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in 35 cycles at 94o C for 30 s, 55oC for 45 s and 72o C
for 1 min; TNF-α G-238A, G-308A F- 50-TCCTGCAT
CCTGTCTGGAAGT-30 and R-50-AgggAgCgTCTgCTgg
CTgggTg-30 in 35 cycles at 94o C for 30 s, 60°C for 45 s
and 72°C for 1 min. Il-28B rs12979860 F- 50- TC
GCCAGGGCCCCTAACCTCTGC-30 and R-50- CGCC
CAGCAGGCGCCTCTCCTA-30 in 35 cycles at 94o C
for 30 s, 58oC for 45 s and 72o C for 1 min and IL-28B
rs8099917 F-50-CCACTTCTGGAACAAATCGTC-30 and
R-50-GATACGCTATAATTAAAGATGTGGA-30 in 35 cycles
at 94o C for 30 s, 54oC for 45 s and 72o C for 1 min. The
amplified products were sequenced using the DYEnamic™
ET Dye Terminator Cycle Sequencing kit for MegaBACE
(Amersham Pharmacia Biotech Inc.).
Statistical analysis was carried out using SPSS v15
Statistical System (Chicago, IL,USA). The Chi-square or
Fisher’s exact method was used to determine deviations
from Hardy-Weinberg Equilibrium and to compare gen-
otypes, allele and phenotype frequencies. The binary lo-
gistic regression analysis was performed with the
polymorphisms that showed significant differences in as-
sociation analyses (P values < 0.05).
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